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Multiple skin metastases to vulva from 
carcinoma of the cervical stump
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 Summary
Metastases to the skin occur rarely in the cervical carcinoma, even in terminal stage of the disease. The frequency 
of metastasis is estimated from 0.01% to 2%. The presence of metastasis suggests generalized dissemination of 
the disease and reflects a rapidly progressive process that appear in the final stage of the disease.
Case: We present a case of skin metastases in patients with squamous cell carcinoma of the cervical stump after 
the previous supracervical hysterectomy for benign disease of the uterus. The extensive skin changes on vulva and 
perineum occurred after radical trachelectomy and external radiation therapy. Patient received HDR brachytherapy 
for recurrent lesions, but the effect of treatment was poor and she died of progressive disease.
Conclusion: As far as we know this is the first case report of squamous cell carcinoma in the cervical stump me-
tastasizing to skin. Palliative brachytherapy has a limited role in controlling symptoms. Skin metastases indicate an 
aggressive and progressive process.
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 Streszczenie
Rak szyjki macicy niezwykle rzadko daje przerzuty do skóry nawet w wysokich stopniach zaawansowania kliniczne-
go. Przedstawiono przypadek chorej z rakiem płaskonabłonkowym w kikucie szyjki macicy poddanej radykalnemu 
leczeniu chirurgicznemu i następowej radioterapii. Po upływie 2 miesięcy od zakończenia terapii u pacjentki stwier-
dzono obecność przerzutów do skóry sromu i krocza. Chorą leczono brachyterapią HDR nie uzyskując zadowa-
lających efektów. Zgodnie z naszą wiedzą jest to pierwszy opis przerzutów raka w kikucie szyjki macicy do skóry. 
Zastosowanie brachyterapii ma ograniczone zastosowanie w leczeniu przerzutów do skóry. Obecność przerzutów 
do skóry wskazuje na agresywny i postępujący przebieg raka szyjki macicy.
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Introduction
Skin	 metastases	 of	 female	 genital	 tract	 malignancies	 are	
exceptionally	 rare,	occurring	most	often	 in	cases	of	breast	and	
ovarian	cancer	[1].	Carcinoma	of	the	uterine	cervix	is	a	common	
cancer	 in	 females	and	 it	metastasizes	mainly	 to	 the	 lung,	bone	
and	liver	[2].	Skin	metastases	from	cervical	cancer	are	extremely	
rare,	even	in	higher	stages	of	clinical	advancement	[3].	It	seems	
that	 in	majority	 of	 patients	 they	 do	 not	 occur	 even	 in	 the	 late	
stages	of	the	disease	[4].
Browstein	and	Helwig	report	only	four	(4)	(2%)	proved	cas-
es	of	cutaneous	metastases	of	the	cervical	cancer	in	their	study	
[1].	However,	in	the	review	by	Brady	et	al.,	only	five	(5)	cervi-
cal	cancer	patients	(0.01%)	developed	skin	metastases	[5].	Gupta	
and	Naran	performed	needle	puncture	of	skin	changes	 in	sixty	
(60)	women	with	cancers	[6].	These	authors	found	that	uterine	
cervix	turned	out	to	be	the	primary	location	of	carcinoma	in	only	
in	three	(3)	women	(5%).	
Based	on	a	review	of	the	literature,	Franciolini	et	al.	report	
only	eleven	 (11)	cases	of	skin	metastases	of	 the	uterine	cervix	
carcinoma	between	 1940	 and	 1990,	while	Hayes	 et	 al.	 inform	
about	22	well-documented	cases	[4,	7].
To	the	best	of	our	knowledge,	this	is	the	first	literature	report	
on	multiple	skin	metastases	in	patients	with	squamous	cell	carci-
noma	of	the	cervical	stump	after	previous	supracervical	hyster-
ectomy	for	benign	uterine	diseases.
Case report
A	47-year-old	woman	with	diagnosed	squamous	cell	carci-
noma	of	 the	cervical	 stump	was	 referred	 to	 the	Department	of	
Oncological	 Gynaecology	 at	 Nicolaus	 Copernicus	 University	
on	November	7,	2002	 in	order	 to	 receive	preoperative	brachy-
therapy.
In	 1993	 the	 patient	 underwent	 supracervical	 subtotal	 hys-
terectomy	due	to	uterine	myoma	after	previous	diagnostic	curet-
tage.	The	result	of	the	postoperative	histopathologic	examination	
revealed	the	presence	of	a	leiomyoma.	Regular	check-up	exami-
nations,	along	with	Pap	smear,	did	not	 reveal	any	pathological	
changes	during	the	years	following	initial	surgery.
Pelvic	examination	before	brachytherapy	revealed	condition	
after	supracervical	hysterectomy,	uterine	adnexa	were	not	palpa-
ble.	The	vaginal	part	of	the	cervix	was	found	to	be	cylindrical,	
expanded,	with	crater-like	ulceration	limited	to	the	cervix,	with-
out	parametrial	extension.	Cervical	biopsy	revealed	FIGO	stage	
IB1	invasive	squamous	cell	carcinoma.	Ultrasound	examination	
indicated	 that	 the	size	of	 the	uterine	cervix	was	53x42x45mm.	
The	patient	underwent	preoperative	intracavitary	brachytherapy.	
Radical	trachelectomy	with	pelvic	and	aortic	lymphadenec-
tomy	was	performed	six	weeks	after	brachytherapy	(Piver	III).	
Pathologic	 examination	 revealed	 a	 cervical	 tumour,	 3.2cm	 in	
diameter.	Foci	of	 squamous	cell	 carcinoma	 infiltrating	 the	cer-
vical	 stump	were	clearly	visible.	The	 lesion	was	 resected	with	
adequate	safe	margins	of	healthy	tissues.	Parametria	and	lymph	
nodes	were	negative	for	neoplastic	invasive	metastases.
Afterwards	 the	 patient	 was	 treated	 by	 external	 radiation	
therapy	 with	 X-rays	 -	 15MeV.	 Teletherapy	 was	 applied	 using	
“box”	 technique	 in	 the	 total	 dose	of	 4500cGy	 (25	 fractions	of	
180cGy\g).
12	weeks	 after	 teletherapy,	 the	patient	 returned	 to	our	de-
partment	due	to	palpable	nodulous	lesions	at	the	perineum.	
The	changes	were	 resected	 for	histopathological	 examina-
tion.	Skin	biopsy	confirmed	metastatic	squamous	cell	carcinoma,	
which	was	histologically	identical	to	the	previous	carcinoma	of	
the	cervix.	No	other	pathological	changes	were	found.
In	 the	 first	 surgically	 removed	 material	 histopathological	
study	 revealed	 	 invasive	 nonkeratinized	moderately	 differenti-
ated	squamous	cell	carcinoma	of	the	cervix	(according	to	WHO	
rules)	[8].	A	clear-cut	connection	to	the	cervical	squamous	epi-
thelium	was	visible	(Figure	A).	
The	second	studied	material	was	surgically	removed	vulvar	
specimen.	In	that	sample	we	observed	irregular	islands	of	mod-
erately	differentiated	squamous	cell	carcinoma,	which	were	not	
connected	to	overlying	skin	(Figure	B).	The	morphology	of	neo-
plasms		in	cervical	and	vulvar	location	was	comparable.	Further	
immunohistochemical	analyses	were	performed	on	both	samples	
to	confirm	the	cervical	origin	of	vulvar	metastases.	
 
Figure A. Tissue specimen from cervix. The infiltrative moderately differentiated 
squamous cell carcinoma is present. There is well visible transition from normal 
(non-neoplastic) squamous epithelium to neoplastic (invasive) one. The brown color 
corresponds to locatisation of cytokeratins with epithelial component in the specimen 
(immunohistochemistry with AE1/AE3 antibodies). The cell nuclei were highlighted by 
Meyer’s hematoxilin staining. Primary objective mag. 4x
 
Figure B. Tissue specimen from vulva. There is well visible nest of metastasis. 
The cancer cells form irregular islands deep within vulvar tissue. The brown color 
corresponds to locatisation of cytokeratins by immunohistochemical procedures with 
AE1/AE3 antibodies within epithelial component (the top of tissue specimen) and 
within cancer cells. The cell nuclei were highlighted by Meyer’s hematoxilin staining. 
Original size scan of tissue slide.
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In	accordance	with	recommendations	published	earlier,	we	
used	p63	(anti-human	p63,	clone	4A4,	cat.	no.	N1604,	DAKO)	
as	a	marker	of	cervical	origin	of	squamous	cell	carcinoma	[9].	
Moreover,	we	used	cytokeratins	panel	(clone	AE1/AE3,	cat.	no.	
1590,	DAKO)	to	confirm	epithelial	origin	of	the	tumor,	as	well	as	
to	exclude	the	possibility	of	the	non-epithelial	tumor.	The	results	
of	the	aforementioned	studies	are	presented	in	Figure	C.
During	the	next	4	weeks	the	patient	was	treated	with	brachy-
therapy	-3000cGy	Ir-192	was	applied	with	the	use	of	3-6	needle-
shaped	 bars	No	16.	Due	 to	 visible	 progression	 of	 the	 changes	
during	the	subsequent	stays	in	hospital,	the	last,	sixth,	scheduled	
fraction	was	cancelled.	Wide-spread	metastatic	vulval	and	peri-
neum	changes	were	found	during	the	examination	(Picture	1).
The	patient	was	examined	again	after	two	months.	The	sur-
roundings	 of	 the	 vulva,	 perineum	 and	 rectum	were	 oedematic	
and	 covered	 with	 nodules	 of	 1.0-1.5cm	 diameter	 (intensively	
infiltrated	skin).	
The	patient	was	disqualified	 from	further	 treatment	as	 she	
had	 already	 received	 her	 lifetime	 dosage	 of	 radiation	 (preop-
erative	brachytherapy,	postoperative	 teletherapy,	brachytherapy	
HDR	 in	 the	 area	of	 the	metastases).	Considering	 the	 advance-
ment	of	the	change	and	its	fast	progression,	chemotherapy	was	
not	initiated	and	the	patient	was	transferred	to	a	local	palliative	
care	unit.	The	patient	died	of	progressive	disease	seven	weeks	
later.
Discussion
Skin	 metastases	 of	 the	 cervical	 carcinoma	 are	 extremely	
rare,	 even	 in	 advanced	 stages	of	 the	disease	 [4,	 10].	 It	 is	 esti-
mated	that	they	appear	only	in	about	0,1-2%	of	patients	with	this	
carcinoma.	
Amit	et	al.	 [11]	report	 that	until	 the	year	2001,	 there	have	
been	 only	 twenty	 two	 (22)	well-documented	 cases	 of	 cervical	
cancer	with	skin	metastases.	Metastases	are	most	often	located	
close	to	the	primary	site	of	the	cancer,	what	suggests	expansion	
of	 the	 carcinoma	process	 through	 lymphatic	 vessels	 pattern	 of	
spread	[12].
Macroscopically,	the	changes	can	have	various	clinical	pres-
entation.	Lesions	may	appear	as	plaques	nodules	or	 inflamma-
tory	telangiectatic	areas.	When	specified	as	nodular,	about	half	
of	lesions	were	solitary	and	the	rest	multiple	[7].	In	our	case	nu-
merous	nodular	changes	embracing	the	vulva	and	perineum	were	
observed.
Imachi	et	al.	found	skin	metastases	in	fifteen	(15)	out	of	1190	
analysed	patients	 (1,3%)	with	cervical	cancer	 [2].	At	 the	 same	
time,	these	authors	did	not	demonstrate	any	relevant	differences	
between	the	degree	of	clinical	advancement	and	the	frequency	of	
the	metastases.	The	authors	observed	nodular	pattern	of	skin	me-
tastases	in	thirteen	(13)	of	fifteen	(15)	patients	(86,7%),	of	which	
66,7%	had	numerous	skin	changes.	However,	only	four	(4)	pa-
tients	had	neither	 local	 recurrence	nor	other	distant	metastases	
at	the	time	of	the	skin	metastases	diagnosis.	It	confirms	that	the	
extensive	skin	metastases	observed	by	us	in	the	patient	in	FIGO	
stage	I	were	a	very	rare	form	of	tumor	metastasizing.
The	mechanisms	leading	to	the	intensive	skin	metastases	in	
patients	with	cervical	cancer,	which	are	resistant	to	chemo-	and	
radiotherapy	treatment,	remain	as	yet	unexplained.	Theories	on	
the	pathophysiology	of	skin	metastases	include	direct	extension	
of	the	tumour,	hematogenous,	lymphatic	and	neoplastic	implants	
[3,	13,	14].
Some	authors	focus	on	rapid	progression	of	neoplastic	proc-
ess	in	HIV	patients	[11,	15].	Since	HIV	infection	was	excluded	
in	our	case,	it	is	difficult	to	explain	both	the	appearance	of	wide-
spread	vulval	skin	metastases	in	such	a	short	time	and	the	refrac-
tion	to	radiotherapy	and	local	brachytherapy	with	Ir-192.	Local	
intradermal	 brachytherapy	 is	 used	 as	 an	 alternative	method	 of	
treatment	in	cases	of	recurrent	or	metastatic	changes.	Some	stud-
ies	show	that	using	interstitial	implants	improves	the	local	state	
and	the	rate	of	survival	in	patients	with	advanced	cervical	cancer	
[6].
Up	to	now	there	have	been	no	standardized	operative	treat-
ment	methods	in	patients	with	benign	disease	of	the	uterus,	par-
ticularly	in	case	of	uterine	myoma.	Some	authors	suggest	routine	
hysterectomy	in	order	to	avoid	cancer	in	the	left	cervical	stump,	
while	others	are	in	favour	of	subtotal	supracervical	hysterectomy	
to	preserve	sexual	function	[16,	17-20].	
 
Figure C. Immunohistochemical localization of  cytokeratins (antibody clone AE1/
AE3) and p63 within squamous cell carcinoma within cervix and vulval mestastases. 
Morphological picture as well as this set of staining confirms a common origin (from 
cervix) neoplastic cells. The cell nuclei were highlighted by Meyer’s hematoxilin stain-
ing. Primary objective mag.
 
Picture 1. 
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The	 frequency	of	 cervical	 cancer	 in	patients	 after	 subtotal	
hysterectomy	is	estimated	between	0.3%	to	3%	[17,	21].
Out	of	6635	cases	of	uterine	cancer	observed	by	Hellstrom	
et	al.,	145	patients	were	treated	for	infiltrating	carcinoma	of	the	
cervical	stump	(2.2%)	[21].
Our	case	of	 carcinoma	 in	 the	 left	 cervical	 stump	with	nu-
merous	vulval	and	perineum	skin	metastases	 in	a	patient	 regu-
larly	examined	could	speak	in	favour	of	the	total	hysterectomy	
for	benign	disease	of	the	uterus,	particularly	in	patients	over	the	
age	of	45.
In	conclusion,	it	should	be	emphasized	that	prognosis	in	pa-
tients	with	skin	metastases	is	usually	poor.	It	seems	that	skin	me-
tastases	are	the	sign	of	generalized	dissemination	of	the	disease	
and	reflect	rapidly	progressive	process	[2,	3].	The	average	period	
of	survival	is	estimated	for	3-4	months	since	the	skin	metastases	
diagnosis	[7,	14].	The	case	presented	here	is	consistent	with	these	
reports.	It	is	the	first	case	report	of	squamous	cell	carcinoma	in	
the	cervical	stump	metastasizing	to	skin.
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